
Omar K. Abughanimeh, MBBS
Advertisement
Articles by Omar K. Abughanimeh, MBBS


This study explores the efficacy and safety of combining docetaxel and capecitabine for treating recurrent or metastatic head and neck cancer.
Advertisement
Latest Updated Articles
A Phase 2 Study of Docetaxel and Capecitabine in Advanced Squamous Cell Carcinoma of the Head and NeckPublished: August 13th 2025 | Updated:
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLCPublished: October 30th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Spotlighting the Top 10 FDA Oncology Approvals in 2025
2
Ivosidenib Combo Shows Preliminary Activity in IDH1-Mutated AML
3
What’s New in Hematology/Oncology? Discussing the 2025 ASH Annual Meeting
4
Nab-Sirolimus Regimens Show Promise in HR+/HER2-Negative Breast Cancer
5

